Target Name: MIR11401
NCBI ID: G113218509
Other Name(s): hsa-mir-11401 | microRNA 11401 | MicroRNA 11401 | hsa-miR-11401

MIR11401: A Potential Drug Target and Biomarker

Molecular Intelligence Research (MIR) has identified MIR11401, a non-coding RNA molecule, as a potential drug target and biomarker in various diseases, including cancer. MIR11401 has been shown to play a crucial role in the regulation of cell growth, apoptosis, and angiogenesis, which are processes that are often disrupted in cancer cells.

The discovery of MIR11401 comes at a time when the development of new cancer treatments is one of the top priorities in the field of medicine. The search for new drug targets and biomarkers has become a major focus of research in the past few decades, with the goal of identifying agents that can effectively treat cancer.

MIR11401 is a small non-coding RNA molecule that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It has been shown to play a role in the regulation of cell growth, apoptosis, and angiogenesis.

One of the key functions of MIR11401 is its role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. MIR11401 has been shown to induce apoptosis in various cell types, including cancer cells, and to play a role in the regulation of apoptosis-mediated cell death.

Another function of MIR11401 is its role in the regulation of angiogenesis, which is the process by which new blood vessels form in the body. MIR11401 has been shown to play a role in the regulation of angiogenesis, including the formation of blood vessels in the placenta and the development of new blood vessels in the brain.

MIR11401 has also been shown to play a role in the regulation of cell growth and division. It has been shown to inhibit the growth of cancer cells and to promote the apoptosis of cancer cells.

The identification of MIR11401 as a potential drug target and biomarker has significant implications for the development of new cancer treatments. It suggests that MIR11401 may be a useful target for cancer therapies that are aimed at inhibiting its activity.

While further research is needed to fully understand the role of MIR11401 in cancer, its potential as a drug target and biomarker is an exciting development in the field of medical research. Further studies are needed to determine the full extent of its potential as a therapeutic agent and to develop new treatments based on its activity.

In conclusion, MIR11401 is a non-coding RNA molecule that has been shown to play a crucial role in the regulation of cell growth, apoptosis, and angiogenesis. Its potential as a drug target and biomarker makes it an attractive target for cancer therapies. Further research is needed to fully understand its role in cancer and to develop new treatments based on its activity.

Protein Name: MicroRNA 11401

More Common Targets

MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1